RuoLan Qian - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

RuoLan Qian

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

Elife|February 22, 2022

A survey of optimal strategy for signature-based drug repositioning and an application to liver cancerChen Yang, Hailin Zhang, Mengnuo Chen, et al.

Genome Medicine|December 16, 2022

Multi-region sequencing with spatial information enables accurate heterogeneity estimation and risk stratification in liver cancerChen Yang, Senquan Zhang, Zhuoan Cheng, et al.

Developmental Cell|January 11, 2025

DYRK1A-TGF-β signaling axis determines sensitivity to OXPHOS inhibition in hepatocellular carcinomaYing Cao, Ruolan Qian, Ruilian Yao, et al.

JHEP Reports : Innovation in Hepatology|September 7, 2023

Loss of hepatic FTCD promotes lipid accumulation and hepatocarcinogenesis by upregulating PPARγ and SREBP2Siying Wang, Yangyang Zhou, Ruobing Yu, et al.

Pageof 2

Search research articles

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

Elife|February 22, 2022

A survey of optimal strategy for signature-based drug repositioning and an application to liver cancerChen Yang, Hailin Zhang, Mengnuo Chen, et al.

Genome Medicine|December 16, 2022

Multi-region sequencing with spatial information enables accurate heterogeneity estimation and risk stratification in liver cancerChen Yang, Senquan Zhang, Zhuoan Cheng, et al.

Developmental Cell|January 11, 2025

DYRK1A-TGF-β signaling axis determines sensitivity to OXPHOS inhibition in hepatocellular carcinomaYing Cao, Ruolan Qian, Ruilian Yao, et al.

JHEP Reports : Innovation in Hepatology|September 7, 2023

Loss of hepatic FTCD promotes lipid accumulation and hepatocarcinogenesis by upregulating PPARγ and SREBP2Siying Wang, Yangyang Zhou, Ruobing Yu, et al.

Pageof 2